Ali Saffaei

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine

Zahra Sahraei, Minoosh Shabani, Shervin Shokouhi et al. · International Journal of Antimicrobial Agents · 2020 · 247 citations · Full text

Coronavirus Disease 2019, Medicine, Antiviral Therapy +5

No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial

Hamidreza Jamaati, Seyed MohammadReza Hashemian, Behrooz Farzanegan et al. · European Journal of Pharmacology · 2021 · 100 citations · Full text

Randomized Clinical Trial, Long Covid, Preliminary Report +4

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial

Payam Tabarsi, Saghar Barati, Hamidreza Jamaati et al. · International Immunopharmacology · 2020 · 83 citations · Full text

Long Covid, Intravenous Immunoglobulin, Covid-19 Pandemic +5

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial

Farzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei et al. · International Immunopharmacology · 2020 · 80 citations · Full text

Non-controlled Prospective Trial, Covid-19 Pandemic, Immunology +5

Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial

Farzaneh Dastan, Ali Saffaei, Sara Haseli et al. · International Immunopharmacology · 2020 · 54 citations · Full text

Covid-19 Pandemic, Immunology, Clinical Trials +5